Publication: Serum Level of Magnesium Attained in Magnesium Sulfate Therapy for Severe Preeclampsia
1
Issued Date
1993-01-01
Resource Type
ISSN
14470756
03892328
03892328
Other identifier(s)
2-s2.0-0027762150
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asia‐Oceania Journal of Obstetrics and Gynaecology. Vol.19, No.4 (1993), 387-390
Suggested Citation
Winit Phuapradit, Nopadol Saropala, Somchai Haruvasin, Pichai Thuvasethakul Serum Level of Magnesium Attained in Magnesium Sulfate Therapy for Severe Preeclampsia. Asia‐Oceania Journal of Obstetrics and Gynaecology. Vol.19, No.4 (1993), 387-390. doi:10.1111/j.1447-0756.1993.tb00398.x Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/22744
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Serum Level of Magnesium Attained in Magnesium Sulfate Therapy for Severe Preeclampsia
Other Contributor(s)
Abstract
Serum magnesium levels were determined in severe preeclampsia patients who were treated with magnesium sulfate infusion. Forty‐four patients with diagnosis of severe preeclampsia between 30–41 weeks gestation, given a conventional 5 g magnesium sulfate intravenous bolus infusion and 1 g/hr continous infusion and continued 24 hours postpartum, were prospectively studied. The mean pre‐treatment magnesium level was 2.3±0.3 mg/dl which was similar to those reports. The levels measured at 1/2, 1, 2, 4, 12 and 24 hours after initiation of magnesium infusion were 4.8±0.4, 4.7±0.4, 4.5±0.3, 4.7±0.3, 5.4±0.3 and 5.9±0.3 mg/dlrespectively. After delivery the levels were measured immediately, 12, and 24 hours and found to be 4.7±0.4, 4.9 ±0.4, and 5.2±0.3 mg/dl respectively. The serum magnesium levels were also varied with maternal weight, the dose regimen used in our study is appropriate for Asian pregnant women whose body weight usually less than 70 kg. © 1993 Japanese Society of Obstetrics and Gynaecology